The value of serial arteriography in osteosarcoma: Delivery of chemotherapy, determination of therapy duration, and prediction of necrosis

Journal of Vascular and Interventional Radiology

Volumn 16, Issue 8, 2005, Pages 1107-1119

  Cullen, John W ^a   Jamroz, Brandt A ^a   Stevens, Sidney L ^a   Madsen, Walt ^a   Hinshaw, Ioana ^a   Wilkins, Ross M ^a   Cullen, Patsy ^a   Camozzi, Anne B ^a   Fink, Kyle ^b   Peck, Sandford D ^a   Kelly, Cynthia M ^a  

^a PRESBYTERIAN ST LUKE S MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; CONTRAST MEDIUM; DOXORUBICIN; FUROSEMIDE; GLUCOSE; GRANISETRON; INFUSION FLUID; IODIXANOL; IOPAMIDOL; MEGLUMINE IOTALAMATE; ONDANSETRON; SODIUM CHLORIDE; VISIPAQUE 320;

ADOLESCENT; ADULT; AGED; ARTERIOGRAPHY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CHILD; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG RESPONSE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; INFANT; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; OSTEOSARCOMA; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; TUMOR NECROSIS; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 23844516685     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000167856.31329.F8     Document Type: Article

References (36)

1. Bacci G, Ferrari S, Tienghi A, et al. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neoadjuvant treatment of osteosarcoma of the extremity. Eur J Surg Oncol 2001; 27:98-104.
2. Benjamin RS, Chawla SP, Carrasco CH, et al. Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum. Ann Oncol 1992; 3(suppl 2):3-6.
3. Ferrari S, Mercuri M, Picci P, et al. Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intra-arterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologie tumor response. Tumori 1999; 85:458-464.
4. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the cooperative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998; 9:893-899.
5. Jaffe N, Knapp J, Chuang VP, et al. Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Cancer 1983; 51:402-407.
6. Jaffe N, Raymond AK, Ayala A, et al. Effect of cumulative courses of intraarterial cis-diamminedichloroplatin-II on the primary tumor in osteosarcoma. Cancer 1989; 63:63-67.
7. Rha SY, Chung HC, Gong SJ, et al. Combined preoperative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma. Oncol Rep 1999; 6:631-637.
8. Winkler K, Bielack S, Delling G, et al. Effect of intra-arterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer 1990; 66:1703-1710.
9. Enneking WF, Spanier SS, Goodham MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980; 153:106-120.
10. Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 10 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone placement. Arch Pathol Lab Med 1977; 101:14-18.
11. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade steosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20:776-790.
12. Davis AM, Bell RS, Goodwin PJ. Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 1994; 12: 424-431.
13. Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997; 15: 76-84.
14. Holscher HC, Hermans J, Nooy MA, et al. Can conventional radiographs be used to monitor the effect of neoadjuvant chemotherapy in patients with osteogenic sarcoma? Skeletal Radiol 1996; 25:19-24.
15. Liszka G, Szendroi M, Szanto J. Response to COSS-86 neoadjuvant therapy assessed by computed tomography and histology. Acta Chir Hung. 1992-93; 33:109-116.
16. Wellings RM, Davies AM, Pynsent PB, Carter SR, Grimer RJ. The value of computed tomographic measurements. Clin Radiol 1994; 49:19-23.
17. Ramanna L, Waxman A, Binney G, et al. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990; 31:567-572.
18. Sanchez RB, Quinn SF, Walling A, Estrada J, Greenberg H. Musculoskeletal neoplasms after intraarterial chemotherapy: Correlation of MR images with pathologic specimens. Radiology 1990; 174:237-240.
19. Kawai A, Sugihara S, Kunisada T, Uchida Y, Inoue H. Imaging assessment of the response of bone tumors to preoperative chemotherapy. Clin Orthop 1997; 337:216-225.
20. Knop J, Delling G, Heise U, Wingler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol 1990; 19: 165-172.
21. Kunisada T, Ozaki T, Kawai A, et al. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy. Cancer 1999; 86:949-956.
22. Franzius C, Scluk J, Brinkschmidt C, Jurgens H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 2000; 25:874-881.
23. Dyke JP, Panicek DM, Healey JH, et al. Osteogenic and Ewing sarcomas: Estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology 2003; 228:271-278.
24. Lang P, Grampp S, Vahlensieck M, et al. Primary bone tumors: value of MR angiography for preoperative planning and monitoring response to chemotherapy. AJR Am J Roentgenol 1995; 165:135-142.
25. Schulte M, Brecht-Krauss D, Werner M, et al. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG-PET. J Nucl Med 1999; 40:1637-1643.
26. Nair N, Ali G, Green AA, et al. Response of osteosarcoma to chemotherapy. Evaluation with F-18 FDG-PET scans. Clin Positron Imaging 2000; 3:79-83.
27. Chuang VP, Benjamin R, Jaffe N, et al. Radiographic and angiographic changes in osteosarcoma after intraarterial chemotherapy. AJR Am J Roentgenol 1982; 139:1065-1069.
28. Bilbao JI, Algarra SM, de Negri JM, et al. Osteosarcoma: Correlation between radiological and histological changes after intra-arterial chemotherapy. Eur J Radiol 1990; 11:98-103.
29. Kumpan W, Lechner G, Wittich GR, et al. The angiographic response of osteosarcoma following preoperative chemotherapy. Skeletal Radiol 1986; 15:96-102.
30. Wilkins RM, Cullen JW, Odom L, et al. Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity. Ann Surg Oncol 2003; 10:498-507.
31. Carrasco CH, Charnsangavej C, Raymond AK, et al. Osteosarcoma: angiographic assessment of response to preoperative chemotherapy. Radiology. 1989; 170(3 Pt 1):839-842.
32. Tsuchiya H, Morinaga T, Taki J, et al. Effect of myocutaneous inflammatory changes caused by intra-arterial chemotherapy on the outcome of patients who undergo limb-saving surgery. Cancer 2001; 91:2447-2453.
33. Bezwada HP, Granick MS, Long CD, et al. Soft tissue complications of intraarterial chemotherapy for extremity sarcomas. Ann Plast Surg 1998; 40:382-387.
34. Cheon JE, Kim IO, Kim WS, et al. Abdominal-wall myositis secondary to intra-arterial chemotherapy for femoral osteosarcoma. Pediatr Radiol 1999; 29: 546-548.
35. Stewart DJ, Benjamin RS, Zimmerman S, et al. Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II). Cancer Res 1983; 43:917-920.
36. Nishimura Y, Yoshimura H, Iwata K, et al. Distribution of pulsed intra arterial infusion chemotherapy in hepatic carcinomas [Japanese]. Gan To Kagaku Ryoho. 1989; 16(suppl):2991-2994.